A herpesvirus kinase that masquerades as Akt: You don't have to look like Akt, to act like it

Cell Cycle

Volumn 10, Issue 13, 2011, Pages 2064-2068

  Chuluunbaatar, Uyanga ^a   Mohr, Ian ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Akt signaling; mTORC1 activation; Translational control; Viral kinase; Virus replication

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3; HERPES VIRUS KINASE; INITIATION FACTOR 3; INITIATION FACTOR 4A; INITIATION FACTOR 4E BINDING PROTEIN 1; INITIATION FACTOR 4G; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAD; PROTEIN KINASE B; PROTEIN US3; S6 KINASE; TUBERIN; UNCLASSIFIED DRUG; VIRUS ENZYME;

ADENOVIRUS; AMINO TERMINAL SEQUENCE; ARTICLE; CELL AGING; CELL CYCLE REGULATION; COMPETITIVE INHIBITION; DIABETES MELLITUS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME SUBSTRATE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES VIRUS; HOST CELL; IMMUNE RESPONSE; MOLECULAR RECOGNITION; NONHUMAN; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; PROTEIN TARGETING; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; VIROGENESIS; VIRUS INFECTION; VIRUS LATENCY; VIRUS REPLICATION;

HERPESVIRIDAE; SIMPLEXVIRUS;

EID: 79959965814     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.13.16242     Document Type: Article

References (47)

1. Ma XM, Blenis J. Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol 2009; 10:307-18.
2. Jackson RJ, Hellen CU, Pestova TV. The mechanism of eukaryotic translation initiation and principles of its regulation. Nat Rev Mol Cell Biol 2010; 11:113-27.
3. Walsh D, Mohr I. Phosphorylation of eIF4E by Mnk-1 enhances HSV-1 translation and replication in quiescent cells. Genes Dev 2004; 18:660-72. (Pubitemid 38489934)
4. Elia A, Constantinou C, Clemens MJ. Effects of protein phosphorylation on ubiquitination and stability of the translational inhibitor protein 4E-BP1. Oncogene 2008; 27:811-22. (Pubitemid 351186316)
5. Braunstein S, Badura ML, Xi Q, Formenti SC, Schneider RJ. Regulation of protein synthesis by ionizing radiation. Mol Cell Biol 2009; 29:5645-56.
6. Richter JD, Sonenberg N. Regulation of cap-dependent translation by eIF4E inhibitory proteins. Nature 2005; 433:477-80. (Pubitemid 40204297)
7. Zoncu R, Efeyan A, Sabatini DM. mTOR: From growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 2011; 12:21-35.
8. Nascimento EB, Ouwens DM. PRAS40: Target or modulator of mTORC1 signalling and insulin action? Arch Physiol Biochem 2009; 115:163-75.
9. Sengupta S, Peterson TR, Sabatini DM. Regulation of the mTOR complex 1 pathway by nutrients, growth factors and stress. Mol Cell 2010; 40:310-22.
10. Ruvinsky I, Meyuhas O. Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. Trends Biochem Sci 2006; 31:342-8. (Pubitemid 43903237)
11. Demidenko ZN, Zubova SG, Bukreeva EI, Pospelov VA, Pospelova TV, Blagosklonny MV. Rapamycin decelerates cellular senescence. Cell Cycle 2009; 8:1888-95.
12. Walsh D, Mohr I. Assembly of an active translation initiation factor complex by a viral protein. Genes Dev 2006; 20:461-72. (Pubitemid 43244400)
13. Kudchodkar SB, Yu Y, Maguire TG, Alwine JC. Human cytomegalovirus infection induces rapamycin-insensitive phosphorylation of downstream effectors of mTOR kinase. J Virol 2004; 78:11030-9. (Pubitemid 39299643)
14. Walsh D, Perez C, Notary J, Mohr I. Regulation of the translation initiation factor eIF4F by multiple mechanisms in human cytomegalovirus-infected cells. J Virol 2005; 79:8057-64. (Pubitemid 40853509)
15. Arias C, Walsh D, Harbell J, Wilson AC, Mohr I. Activation of host translational control pathways by a viral developmental switch. PLoS Pathog 2009; 5:1000334.
16. Moorman NJ, Shenk T. Rapamycin-resistant mTORC1 kinase activity is required for herpesvirus replication. J Virol 2010; 84:5260-9.
17. Chuluunbaatar U, Roller R, Feldman ME, Brown S, Shokat KM, Mohr I. Constitutive mTORC1 activation by a herpesvirus Akt surrogate stimulates mRNA translation and viral replication. Genes Dev 2010; 24:2627-39.
18. Perez C, McKinney C, Chulunbaatar U, Mohr I. Translational control of the abundance of cytoplasmic poly(A) binding protein in human cytomegalovirus- infected cells. J Virol 2011; 85:156-64.
19. Hale BG, Jackson D, Chen YH, Lamb RA, Randall RE. Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling. Proc Natl Acad Sci USA 2006; 103:14194-9. (Pubitemid 44453002)
20. Ehrhardt C, Wolff T, Pleschka S, Planz O, Beermann W, Bode JG, et al. Influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses. J Virol 2007; 81:3058-67. (Pubitemid 46456615)
21. Wagner MJ, Smiley JR. Herpes simplex virus requires VP11/12 to activate Src family kinase-phosphoinositide-3-Kinase-Akt signaling. J Virol 2011; 85:2803-12.
22. Buchkovich NJ, Yu Y, Zampieri CA, Alwine JC. The TORrid affairs of viruses: Effects of mammalian DNA viruses on the PI3K-Akt-mTOR signaling pathway. Nat Rev Microbiol 2008; 6:266-75.
23. Harrington LS, Findlay GM, Lamb RF. Restraining PI3K: mTOR signaling goes back to the membrane. Trends Biochem Sci 2005; 30:35-42. (Pubitemid 40093739)
24. Benetti L, Roizman B. Protein kinase B/Akt is present in activated form throughout the entire replicative cycle of deltaU(S)3 mutant virus but only at early times after infection with wild-type herpes simplex virus 1. J Virol 2006; 80:3341-8.
25. Dibble CC, Asara JM, Manning BD. Characterization of Rictor phosphorylation sites reveals direct regulation of mTOR complex 2 by S6K1. Mol Cell Biol 2009; 29:5657-70.
26. Moorman NJ, Cristea IM, Terhune SS, Rout MP, Chait BT, Shenk T. Human cytomegalovirus protein UL38 inhibits host cell stress responses by antagonizing the tuberous sclerosis protein complex. Cell Host Microbe 2008; 3:253-62. (Pubitemid 351494714)
27. Lu Z, Hu X, Li Y, Zheng L, Zhou Y, Jiang H, et al. Human papillomavirus 16 E6 oncoprotein interferences with insulin signaling pathway by binding to tuberin. J Biol Chem 2004; 279:35664-70. (Pubitemid 39100569)
28. Inoki K, Zhu T, Guan KL. TSC2 mediates cellular energy response to control cell growth and survival. Cell 2003; 115:577-90. (Pubitemid 37506046)
29. Budanov AV, Karin M. p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell 2008; 134:451-60.
30. Inoki K, Ouyang H, Zhu T, Lindvall C, Wang Y, Zhang X, et al. TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell 2006; 126:955-68. (Pubitemid 44310775)
31. DeYoung MP, Horak P, Sofer A, Sgroi D, Ellisen LW. Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling. Genes Dev 2008; 22:239-51.
32. Sehgal SN. Sirolimus: Its discovery, biological properties and mechanism of action. Transplant Proc 2003; 35:7-14.
33. Munger J, Roizman B. The US3 protein kinase of herpes simplex virus 1 mediates the posttranslational modification of BAD and prevents BAD-induced programmed cell death in the absence of other viral proteins. Proc Natl Acad Sci USA 2001; 98:10410-5. (Pubitemid 32803033)
34. Kato A, Yamamoto M, Ohno T, Kodaira H, Nishiyama Y, Kawaguchi Y. Identification of proteins phosphorylated directly by the Us3 protein kinase encoded by herpes simplex virus 1. J Virol 2005; 79:9325-31. (Pubitemid 40934845)
35. Mou F, Forest T, Baines JD. US3 of herpes simplex virus type 1 encodes a promiscuous protein kinase that phosphorylates and alters localization of lamin A/C in infected cells. J Virol 2007; 81:6459-70. (Pubitemid 46878051)
36. Leach N, Bjerke SL, Christensen DK, Bouchard JM, Mou F, Park R, et al. Emerin is hyperphosphorylated and redistributed in herpes simplex virus type 1-infected cells in a manner dependent on both UL34 and US3. J Virol 2007; 81:10792-803. (Pubitemid 47463352)
37. Meignier B, Longnecker R, Mavromara-Nazos P, Sears AE, Roizman B. Virulence of and establishment of latency by genetically engineered deletion mutants of herpes simplex virus 1. Virology 1988; 162:251-4. (Pubitemid 18063116)
38. Nishiyama Y, Yamada Y, Kurachi R, Daikoku T. Construction of a US3 lacZ insertion mutant of herpes simplex virus type 2 and characterization of its phenotype in vitro and in vivo. Virology 1992; 190:256-68.
39. Ryckman BJ, Roller RJ. Herpes simplex virus type 1 primary envelopment: UL34 protein modification and the US3-UL34 catalytic relationship. J Virol 2004; 78:399-412. (Pubitemid 37549751)
40. Camarena V, Kobayashi M, Kim JY, Roehm P, Perez R, Gardner J, et al. Nature and duration of growth factor signaling through receptor tyrosine kinases regulates HSV-1 latency in neurons. Cell Host Microbe 2010; 8:320-30.
41. Leader DP, Deana AD, Marchiori F, Purves FC, Pinna LA. Further definition of the substrate specificity of the alpha-herpesvirus protein kinase and comparison with protein kinases A and C. Biochim Biophys Acta 1991; 1091:426-31.
42. Biondi RM, Nebreda AR. Signaling specificity of Ser/Thr protein kinases through docking-site-mediated interactions. Biochem J 2003; 372:1-13. (Pubitemid 36609602)
43. Pawson T, Nash P. Protein-protein interactions define specificity in signal transduction. Genes Dev 2000; 14:1027-47. (Pubitemid 30324418)
44. Reményi A, Good MC, Lim WA. Docking interactions in protein kinase and phosphatase networks. Curr Opin Struct Biol 2006; 16:676-85. (Pubitemid 44827730)
45. Söderberg BO, Sjöberg BM, Sonnerstam U, Brändén CI. Three-dimensional structure of thioredoxin induced by bacteriophage T4. Proc Natl Acad Sci USA 1978; 75:5827-30.
46. Matthews BW, Grutter MG, Anderson WF, Remington SJ. Common precursor of lysozymes of hen egg-white and bacteriophage T4. Nature 1981; 290:334-5. (Pubitemid 11107246)
47. Lesk A, Chothia C. How different amino acid sequences determine similar protein structures: The structure and evolutionary dynamics of the globins. J Mol Biol 1980; 136:225-70.